Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash from Financing Activities (2023 - 2025)

Cannabis Bioscience International Holdings filings provide 3 years of Cash from Financing Activities readings, the most recent being $156716.0 for Q2 2025.

  • On a quarterly basis, Cash from Financing Activities fell 10.14% to $156716.0 in Q2 2025 year-over-year; TTM through May 2025 was $341824.0, a 27.46% decrease, with the full-year FY2025 number at $341824.0, down 27.46% from a year prior.
  • Cash from Financing Activities reached $156716.0 in Q2 2025 per CBIH's latest filing, up from $82358.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $216837.0 in Q4 2023, with the low at $9534.0 in Q1 2024.
  • A 3-year average of $118690.2 and a median of $119537.0 in 2025 define the central range for Cash from Financing Activities.
  • Year-over-year, Cash from Financing Activities plummeted 95.3% in 2024 and then skyrocketed 763.83% in 2025.
  • Year by year, Cash from Financing Activities stood at $216837.0 in 2023, then plummeted by 66.74% to $72123.0 in 2024, then surged by 117.29% to $156716.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Cash from Financing Activities are $156716.0 (Q2 2025), $82358.0 (Q1 2025), and $72123.0 (Q4 2024).